aap Implantate Presents Pipeline of 11 Product Development Projects Through 2031

PUBT · 2d ago
aap Implantate Presents Pipeline of 11 Product Development Projects Through 2031
  • aap Implantate reported positive EBITDA for the first nine months of 2026 in an investor presentation in Berlin.
  • Third-quarter revenue rose 2% to EUR 3.3 million, while US revenue increased 15% in dollar terms over nine months.
  • Planned investment of approximately EUR 1.25 million will expand and automate Berlin production capacity over 2026-2028 and beyond.
  • The development pipeline includes 11 projects through 2031, with a budget of EUR 2.5 million to EUR 3.2 million.
  • A human study of the antibacterial silver coating concluded successfully, with the technology progressing toward marketing authorization.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. aap Implantate AG published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.